RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BARRINGTON S
Collezione AO Cuneo

Items : 6

International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline (18)F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation. in Journal of nuclear medicine : official publication, Society of Nuclear Medicine / J Nucl Med. 2024 Sep 3;65(9):1343-1348. doi: 10.2967/jnumed.124.267789.

2024
AO Cuneo

Boellaard R; Buvat I; Nioche C; Ceriani L; Cottereau AS; Guerra L; Hicks RJ; Kanoun S; Kobe C; Loft A; Schöder H; Versari A; Voltin CA; Zwezerijnen GJC; Zijlstra JM; Mikhaeel NG; Gallamini A; El-Galaly TC; Hanoun C; Chauvie S; Ricci R; Zucca E; Meignan M; Barrington SF;

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Dec;42(34):4071-4083. doi: 10.1200/JCO-24-01373. Epub 2024 Aug 19.

2024
AO Cuneo
AOU Città della Salute di Torino

Davies A; Zucca E; Johnson PWM; Cavalli F; Gospodarowicz M; Trneny M; Walewski J; Versari A; Chauvie S; Metser U; Malkowski B; Olivieri J; Petrucci L; Barrington SF; Puccini B; Re A; Vitolo U; Santoro A; Stepanishyna Y; Di Rocco A; Jerkeman M; Cwynarski K; Mikhaeel G; Janikova A; Spina M; Fosså A; Lucchini E; Ionescu C; Minoia C; et alii...

Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study. in Hematological oncology / Hematol Oncol. 2017 Dec;35(4):548-553. doi: 10.1002/hon.2339. Epub 2016 Aug 22.

2017
AO Cuneo

Ceriani L; Barrington S; Biggi A; Malkowski B; Metser U; Versari A; Martelli M; Davies A; Johnson PW; Zucca E; Chauvie S;

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. in Haematologica / Haematologica. 2014 Jun;99(6):1107-13. doi: 10.3324/haematol.2013.103218. Epub 2014 Mar 21.

2014
AO Cuneo

Gallamini A; Barrington SF; Biggi A; Chauvie S; Kostakoglu L; Gregianin M; Meignan M; Mikhaeel GN; Loft A; Zaucha JM; Seymour JF; Hofman MS; Rigacci L; Pulsoni A; Coleman M; Dann EJ; Trentin L; Casasnovas O; Rusconi C; Brice P; Bolis S; Viviani S; Salvi F; Luminari S; Hutchings M;

International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. in Journal of nuclear medicine : official publication, Society of Nuclear Medicine / J Nucl Med. 2013 May;54(5):683-90. doi: 10.2967/jnumed.112.110890. Epub 2013 Mar 20.

2013
AO Cuneo

Biggi A; Gallamini A; Chauvie S; Hutchings M; Kostakoglu L; Gregianin M; Meignan M; Malkowski B; Hofman MS; Barrington SF;

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses. in British journal of haematology / Br J Haematol. 2011 Mar;152(5):551-60. doi: 10.1111/j.1365-2141.2010.08485.x. Epub 2010 Dec 20.

2011
AO Cuneo

Gallamini A; Patti C; Viviani S; Rossi A; Fiore F; Di Raimondo F; Cantonetti M; Stelitano C; Feldman T; Gavarotti P; Sorasio R; Mulè A; Leone M; Rambaldi A; Biggi A; Barrington S; Fallanca F; Ficola U; Chauvie S; Gianni AM;